Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-17-063100
Filing Date
2017-12-11
Accepted
2017-12-11 14:58:32
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tv481073_424b5.htm 424B5 357657
2 GRAPHIC tv480924_img1.jpg GRAPHIC 8806
3 GRAPHIC tv480924_img3.jpg GRAPHIC 1664
4 GRAPHIC tv480924_img2.jpg GRAPHIC 9065
  Complete submission text file 0001144204-17-063100.txt   386244
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221093 | Film No.: 171249341
SIC: 2836 Biological Products, (No Diagnostic Substances)